Original scientific paper

The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis

Sylejman Rexhepi orcid.org/0000-0003-4839-9906 ; Department of Rheumatology, Clinic for Internal Medicine, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Mjellma Rexhepi ; Department of Rheumatology, Clinic for Internal Medicine, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Vjollca Sahatçiu-Meka ; Physical Medicine Department, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Argjend Tafaj ; Rheumatology Department, Faculty of Medicine, University of Tirana, Tirana, Albania
Remzi Izairi ; Faculty of Medicine, State University of Tetova, Tetova, Macedonia
Blerta Rexhepi ; Faculty of Medicine, University of Prishtina, Prishtina, Kosovo

Abstract

The study presents the results of predicting role of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, compared to rheumatoid factor. 32 patients with rheumatoid arthritis were identified from a retrospective chart review.
The results of our study show that presence of the rheumatoid factor has less diagnostic and prognostic significance than the anti-cyclic citrullinated peptide, and suggests its superiority in predicting an erosive disease course.

Keywords

rheumatoid arthritis; anti-cyclic citrullinated peptide antibody; rheumatoid factor

Hrčak ID:

124553

URI

https://hrcak.srce.hr/124553

Publication date:

1.6.2011.

Article data in other languages: croatian

Visits: 1.091 *